English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Repare Therapeutics (RPTX.US)$ Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
5 MINUTES AGO, 7:05 AM EDT
VIA BUSINESSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
9766 Views
Comment
Sign in to post a comment
    5120
    Followers
    23
    Following
    74K
    Visitors
    Follow